1. Gerard K, Mooney, G. QALY league tables: Handle with care. Health Econ; 1993. p. 59-64.
  2. Bertram MY, Lauer JA, De Joncheere K, Edejer T, Hutubessy R, Kieny MP, et al. Cost-effectiveness thresholds: pros and cons. Bull World Health Organ. 2016;94(12):925-30.
  3. Claxton K, Martin S, Soares M, Rice N, Spackman E, Hinde S, et al. Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. Health Technol Assess. 2015;19(14):1-503, v-vi.
  4. Drummond MF, Sculpher, MJ, Claxton, K, Stoddart, GL and GW Torrance. Methods for the Economic Evaluation of Health Care Programmes. Fourth edition ed: Oxford university press; 2015.
  5. Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S. Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ. 2015;93(2):118-24.
  6. Drummond M, Torrance, G and J Mason.  Cost-effectiveness league tables: more harm than good? Soc Sci Med. 1993;37(1):33-40.
  7. Gray A, Clarke, P. M., Wolstenholme, J. L. and Wordsworth, S. Applied Methods of Cost-effectiveness Analysis in Healthcare: Oxford University Press; 2010.
  8. Vallejo-Torres L, Garcia-Lorenzo B, Castilla I, Valcarcel-Nazco C, Garcia-Perez L, Linertova R, et al. On the Estimation of the Cost-Effectiveness Threshold: Why, What, How? Value in health: he journal of the International Society for Pharmacoeconomics and Outcomes Research. 2016;19(5):558-66.
  9. Eichler HG, Kong SX, Gerth WC, Mavros P, Jonsson B. Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2004;7(5):518-28.
  10. Petrou S, Malek M, Davey PG. The reliability of cost-utility estimates in cost-per-QALY league tables. Pharmacoeconomics. 1993;3(5):345-53.
  11. Culyer AJ. Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use. Health Econ Policy Law. 2016;11(4):415-32.
  12. Woods B, Revill, P., Sculpher, M. and Claxton, K. Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research. Value in Health. 2016;19(8):929-35.
  13. Revill P, Ochalek, J., Lomas, J., Nakamura, R., Woods, B., Rollinger, A., Suhrcke, M., Sculpher, M. and Claxton, K. Cost-effectiveness thresholds: guiding health care spending for population health improvement. International Decision Support Initiative. 2015.